Cargando…

The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients

BACKGROUND: Inherited protein S deficiency is a thrombophilic risk factor associated with venous thromboembolism. However, there is not much data on the impact of mutation position on thrombotic risk. OBJECTIVES: The aim of this study was to evaluate the risk of thrombosis due to mutations located i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenclova, Tereza, Matyskova, Miloslava, Provaznikova, Dana, Marecek, Frantisek, Geierova, Vera, Kovarova-Kudrnova, Zuzana, Hrachovinova, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293767/
https://www.ncbi.nlm.nih.gov/pubmed/37384225
http://dx.doi.org/10.1016/j.rpth.2023.100194
_version_ 1785063061151809536
author Fenclova, Tereza
Matyskova, Miloslava
Provaznikova, Dana
Marecek, Frantisek
Geierova, Vera
Kovarova-Kudrnova, Zuzana
Hrachovinova, Ingrid
author_facet Fenclova, Tereza
Matyskova, Miloslava
Provaznikova, Dana
Marecek, Frantisek
Geierova, Vera
Kovarova-Kudrnova, Zuzana
Hrachovinova, Ingrid
author_sort Fenclova, Tereza
collection PubMed
description BACKGROUND: Inherited protein S deficiency is a thrombophilic risk factor associated with venous thromboembolism. However, there is not much data on the impact of mutation position on thrombotic risk. OBJECTIVES: The aim of this study was to evaluate the risk of thrombosis due to mutations located in the sex hormone–binding globulin (SHBG)–like region as opposed to the rest of the protein. METHODS: Genetic analysis of PROS1 was performed in 76 patients with suspected inherited protein S deficiency, and the effect of missense mutations present in the SHBG region on thrombosis risk was analyzed by statistical methods. RESULTS: We found 30 unique mutations (13 of them novel), of which 17 were missense mutations, in 70 patients. Patients with missense mutations were then divided into 2 groups: the “SHBG-region” mutation group (27 patients) and the “non-SHBG” group (24 patients). The multivariable binary logistic regression analysis showed that mutation position in the SHBG region of protein S is an independent risk factor for thrombosis in deficient patients (OR, 5.17; 95% CI, 1.29-20.65; P = .02). The patients with a mutation in the SHBG-like region also developed a thrombotic event at a younger age compared to the “non-SHBG” group in the Kaplan-Meier analysis (median thrombosis-free survival of 33 vs 47 years, respectively; P = .018). CONCLUSION: Our findings show that a missense mutation located in the SHBG-like region may contribute to higher thrombotic risk rather than a missense mutation located elsewhere in the protein. However, as our cohort was relatively small, these findings should be taken with this limitation.
format Online
Article
Text
id pubmed-10293767
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102937672023-06-28 The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients Fenclova, Tereza Matyskova, Miloslava Provaznikova, Dana Marecek, Frantisek Geierova, Vera Kovarova-Kudrnova, Zuzana Hrachovinova, Ingrid Res Pract Thromb Haemost Original Article BACKGROUND: Inherited protein S deficiency is a thrombophilic risk factor associated with venous thromboembolism. However, there is not much data on the impact of mutation position on thrombotic risk. OBJECTIVES: The aim of this study was to evaluate the risk of thrombosis due to mutations located in the sex hormone–binding globulin (SHBG)–like region as opposed to the rest of the protein. METHODS: Genetic analysis of PROS1 was performed in 76 patients with suspected inherited protein S deficiency, and the effect of missense mutations present in the SHBG region on thrombosis risk was analyzed by statistical methods. RESULTS: We found 30 unique mutations (13 of them novel), of which 17 were missense mutations, in 70 patients. Patients with missense mutations were then divided into 2 groups: the “SHBG-region” mutation group (27 patients) and the “non-SHBG” group (24 patients). The multivariable binary logistic regression analysis showed that mutation position in the SHBG region of protein S is an independent risk factor for thrombosis in deficient patients (OR, 5.17; 95% CI, 1.29-20.65; P = .02). The patients with a mutation in the SHBG-like region also developed a thrombotic event at a younger age compared to the “non-SHBG” group in the Kaplan-Meier analysis (median thrombosis-free survival of 33 vs 47 years, respectively; P = .018). CONCLUSION: Our findings show that a missense mutation located in the SHBG-like region may contribute to higher thrombotic risk rather than a missense mutation located elsewhere in the protein. However, as our cohort was relatively small, these findings should be taken with this limitation. Elsevier 2023-05-24 /pmc/articles/PMC10293767/ /pubmed/37384225 http://dx.doi.org/10.1016/j.rpth.2023.100194 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Fenclova, Tereza
Matyskova, Miloslava
Provaznikova, Dana
Marecek, Frantisek
Geierova, Vera
Kovarova-Kudrnova, Zuzana
Hrachovinova, Ingrid
The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
title The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
title_full The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
title_fullStr The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
title_full_unstemmed The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
title_short The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
title_sort impact of pros1 mutation position on thrombotic risk in protein s–deficient patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293767/
https://www.ncbi.nlm.nih.gov/pubmed/37384225
http://dx.doi.org/10.1016/j.rpth.2023.100194
work_keys_str_mv AT fenclovatereza theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT matyskovamiloslava theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT provaznikovadana theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT marecekfrantisek theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT geierovavera theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT kovarovakudrnovazuzana theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT hrachovinovaingrid theimpactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT fenclovatereza impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT matyskovamiloslava impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT provaznikovadana impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT marecekfrantisek impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT geierovavera impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT kovarovakudrnovazuzana impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients
AT hrachovinovaingrid impactofpros1mutationpositiononthromboticriskinproteinsdeficientpatients